A phase 2 trial of complete resection for stage IV melanoma

Results of Southwest Oncology Group Clinical Trial S9430


  • David W. Ollila MD

    Corresponding author
    1. Division of Surgical Oncology and Endocrine Surgery, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
    • Department of Surgery, CB #7213, 170 Manning Drive, 1150 POB, Chapel Hill, NC 27599-7213
    Search for more papers by this author
    • Fax: (919) 966-8806

  • See referenced original article on pages 4740-6, this issue.


This is a concise editorial looking at the evidence for metastasectomy in stage IV melanoma patients. This includes an updated review of the Southwest Oncology Group data.